Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
Hassan
C
C
Zullo
A
A
Ierardi
E
E
Burattini
O
O
De Francesco
V
V
Morini
S
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003092:Colitis / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003106:Colon / Q000473:pathology; D004241:Diverticulum, Colon / Q000188:drug therapy*; D015536:Down-Regulation / Q000502:physiology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab